CEL-SCI CORPORATION Deferred Rent Credit
CEL-SCI CORPORATION (CVM) had Deferred Rent Credit of $3.31 thousand as of 2016-09-30, per its 10-K filed 2016-12-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRentCredit · last filed 2016-12-15
- 2016-09-30: Deferred Rent Credit $3.31K.
- 2016-06-30: Deferred Rent Credit $4.04K.
- 2016-03-31: Deferred Rent Credit $5.92K.
- 2015-12-31: Deferred Rent Credit $6.41K.
| Period end | Deferred Rent Credit |
|---|---|
| 2016-09-30 | $3.31K 10-K · filed 2016-12-15 |
| 2016-06-30 | $4.04K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $5.92K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $6.41K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $10.00K 10-K · filed 2016-12-15 |
| 2015-06-30 | $2.98K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $4.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $5.07K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $6.38K 10-K · filed 2015-12-11 |
| 2014-06-30 | $9.45K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $10.02K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $9.27K 10-Q · filed 2014-02-10 |
| 2013-09-30 | $8.53K 10-K · filed 2014-12-23 |
| 2013-06-30 | $7.78K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $7.06K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $6.13K 10-Q · filed 2013-02-08 |
| 2012-09-30 | $4.20K 10-K · filed 2013-12-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |